Dr. Jesse Wade Keller, MD

Dr. Keller practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Keller's NPI, 1174787162, was assigned on July 18, 2008. Dr. Keller graduated from Johns Hopkins University School of Medicine in 2009. Dr. Keller holds Missouri license 2013011512.

Dr. Keller's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Keller also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Keller's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Keller is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Keller to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keller practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Keller's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Keller is board certified in hematology by the American Board of Internal Medicine. Dr. Keller is licensed in Missouri.

CMS data shows 7,965 Medicare services from Dr. Keller across 12 procedure codes in 2024, for 167 Medicare patients. Medicare paid $209,000 for them. Every service was in an office.

CMS counts 167 Medicare patients who saw Dr. Keller in 2024. The largest group is 65 to 74, with 72 patients. 69% of them have high cholesterol, and 68% have high blood pressure. 7% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Keller's median patient age at 73, with 43% women.

In 2024, Dr. Keller wrote 330 Medicare Part D claims for 54 patients. 68% of them were for generic drugs. CMS names the drug for 173 of them, across 8 drugs with 11 or more claims each, at $855,444 in total drug cost. In 2023, CMS named 186 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Keller for performance year 2024, reported as part of a group. Dr. Keller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Keller as offering telehealth.

CMS Open Payments shows 22 general payments to Dr. Keller from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Celgene Corporation paid the most, $359.

Dr. Keller graduated from Johns Hopkins University School of Medicine in 2009.